Conference
A phase II, randomized trial (CONCERT-1) of chemoradiotherapy (CRT) with or without panitumumab (pmab) in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (LASCCHN).
Abstract
5502
Authors
Giralt J; Fortin A; Mesia R; Minn H; Henke M; Yunes Ancona A; Cmelak A; Markowitz AB; Hotte SJ; Singh S
Volume
30
Pagination
pp. 5502-5502
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2012
DOI
10.1200/jco.2012.30.15_suppl.5502
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X